Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Other Issues:
Previous Next
  [Index by Author]
 
Contents: Volume 19, Issue 12
June 15, 2001
 

Down ORIGINAL REPORTS
  Down Gynecologic Cancer
  Down Hematologic Malignancies
  Down Head and Neck Cancer
  Down Genitourinary Cancer
  Down Surgical Oncology
  Down Sarcomas
  Down Gastrointestinal Cancer
  Down Pediatric Oncology
  Down Breast Cancer
  Down Phase I and Clinical Pharmacology
Down SPECIAL ARTICLES
Down SPECIAL DEPARTMENTS
  Down CORRESPONDENCE

Find articles in this issue containing these words:
[Search ALL Issues]


To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

 
ORIGINAL REPORTS Back

Gynecologic Cancer Back

Phase II Study of Paclitaxel and Valspodar (PSC 833) in Refractory Ovarian Carcinoma: A Gynecologic Oncology Group Study
  Paula M. Fracasso, Mark F. Brady, David H. Moore, Joan L. Walker, Peter G. Rose, Laurie Letvak, Thomas M. Grogan, and William P. McGuire
  JCO Jun 15 2001: 2975–2982. [Abstract] [Full Text] [PDF]  
Phase I/II Trial of the Multidrug-Resistance Modulator Valspodar Combined With Cisplatin and Doxorubicin in Refractory Ovarian Cancer
  Mark Baekelandt, Gustav Lehne, Claes G. Tropé, István Szántó, Per Pfeiffer, Bengt Gustavssson, and Gunnar B. Kristensen
  JCO Jun 15 2001: 2983–2993. [Abstract] [Full Text] [PDF]  

Hematologic Malignancies Back

Bone Marrow Features Improve Prognostic Efficiency in Multivariate Risk Classification of Chronic-Phase Ph1+ Chronic Myelogenous Leukemia: A Multicenter Trial
  Hans Michael Kvasnicka, Juergen Thiele, Annette Schmitt-Graeff, Volker Diehl, Rudolf Zankovich, Norbert Niederle, Lutz-Dietrich Leder, and Hans Eckart Schaefer
  JCO Jun 15 2001: 2994–3009. [Abstract] [Full Text] [PDF]  

Head and Neck Cancer Back

Combined Interferon-Alfa, 13-cis-Retinoic Acid, and Alpha-Tocopherol in Locally Advanced Head and Neck Squamous Cell Carcinoma: Novel Bioadjuvant Phase II Trial
  Dong M. Shin, Fadlo R. Khuri, Barbara Murphy, Adam S. Garden, Gary Clayman, Marites Francisco, Diane Liu, Bonnie S. Glisson, Lawrence Ginsberg, Vassiliki Papadimitrakopoulou, Jeffrey Myers, William Morrison, Ann Gillenwater, K. Kian Ang, Scott M. Lippman, Helmuth Goepfert, and Waun Ki Hong
  JCO Jun 15 2001: 3010–3017. [Abstract] [Full Text] [PDF]  

Genitourinary Cancer Back

Paclitaxel and Gemcitabine Chemotherapy for Advanced Transitional-Cell Carcinoma of the Urothelial Tract: A Phase II Trial of the Minnie Pearl Cancer Research Network
  Anthony A. Meluch, F. Anthony Greco, Howard A. Burris, III, Timothy O’Rourke, Gregory Ortega, Ronald G. Steis, Lisa H. Morrissey, Valerie Johnson, and John D. Hainsworth
  JCO Jun 15 2001: 3018–3024. [Abstract] [Full Text] [PDF]  
Prognostic Significance of Reverse Transcriptase Polymerase Chain Reaction for Prostate-Specific Antigen in Men With Hormone-Refractory Prostate Cancer
  Philip W. Kantoff, Susan Halabi, Deborah A. Farmer, Daniel F. Hayes, Nicholas A. Vogelzang, and Eric J. Small
  JCO Jun 15 2001: 3025–3028. [Abstract] [Full Text] [PDF]  
Clinical Impact of Germ Cell Tumor Cells in Apheresis Products of Patients Receiving High-Dose Chemotherapy
  C. Bokemeyer, A. J.M. Gillis, K. Pompe, F. Mayer, B. Metzner, N. Schleucher, J. Schleicher, G. Pflugrad-Jauch, J. W. Oosterhuis, L. Kanz, and L. H.J. Looijenga
  JCO Jun 15 2001: 3029–3036. [Abstract] [Full Text] [PDF]  

Surgical Oncology Back

Clinicopathologic Features of Long-Term Survivors and Disease-Free Survivors After Resection of Hepatocellular Carcinoma: A Study of a Prospective Cohort
  Ronnie Tung-Ping Poon, Irene Oi-Lin Ng, Sheung-Tat Fan, Edward Cheuk-Sin Lai, Chung-Mau Lo, Chi-Leung Liu, and John Wong
  JCO Jun 15 2001: 3037–3044. [Abstract] [Full Text] [PDF]  

Sarcomas Back

Clinicopathologic Re-Evaluation of 100 Malignant Fibrous Histiocytomas: Prognostic Relevance of Subclassification
  Christopher D.M. Fletcher, Pelle Gustafson, Anders Rydholm, Helena Willén, and Måns Åkerman
  JCO Jun 15 2001: 3045–3050. [Abstract] [Full Text] [PDF]  

Gastrointestinal Cancer Back

Prognostic Value of Initial Fasting Serum Gastrin Levels in Patients With Zollinger-Ellison Syndrome
  Adam C. Berger, Fathia Gibril, David J. Venzon, John L. Doppman, Jeffrey A. Norton, David L. Bartlett, Steven K. Libutti, Robert T. Jensen, and H. Richard Alexander
  JCO Jun 15 2001: 3051–3057. [Abstract] [Full Text] [PDF]  
Prediction of Response to Preoperative Chemotherapy in Adenocarcinomas of the Esophagogastric Junction by Metabolic Imaging
  Wolfgang A. Weber, Katja Ott, Karen Becker, Hans-Joachim Dittler, Hermann Helmberger, Norbert E. Avril, Günther Meisetschläger, Raymonde Busch, Jörg-Rüdiger Siewert, Markus Schwaiger, and Ulrich Fink
  JCO Jun 15 2001: 3058–3065. [Abstract] [Full Text] [PDF]  

Pediatric Oncology Back

Bony Morbidity in Children Treated for Acute Lymphoblastic Leukemia
  Adam J. Strauss, Joyce T. Su, Virginia M. Kimball Dalton, Richard D. Gelber, Stephen E. Sallan, and Lewis B. Silverman
  JCO Jun 15 2001: 3066–3072. [Abstract] [Full Text] [PDF]  
Improved Outcome for Patients With Middle Ear Rhabdomyosarcoma: A Children’s Oncology Group Study
  Douglas S. Hawkins, James R. Anderson, Charles N. Paidas, Moody D. Wharam, Stephen J. Qualman, Alberto S. Pappo, K. Scott Baker, and William M. Crist
  JCO Jun 15 2001: 3073–3079. [Abstract] [Full Text] [PDF]  
Comprehensive Genetic and Histopathologic Study Reveals Three Types of Neuroblastoma Tumors
  Maria Lastowska, Catherine Cullinane, Sadick Variend, Simon Cotterill, Nick Bown, Seamus O’Neill, Katia Mazzocco, Paul Roberts, James Nicholson, Caroline Ellershaw, Andrew D.J. Pearson, and Michael S. Jackson
  JCO Jun 15 2001: 3080–3090. [Abstract] [Full Text] [PDF]  
Intergroup Rhabdomyosarcoma Study-IV: Results for Patients With Nonmetastatic Disease
  William M. Crist, James R. Anderson, Jane L. Meza, Christopher Fryer, R. Beverly Raney, Frederick B. Ruymann, John Breneman, Stephen J. Qualman, Eugene Wiener, Moody Wharam, Thom Lobe, Bruce Webber, Harold M. Maurer, and Sarah S. Donaldson
  JCO Jun 15 2001: 3091–3102. [Abstract] [Full Text] [PDF]  

Breast Cancer Back

Phase III Trial Comparing Two Dose Levels of Epirubicin Combined With Cyclophosphamide With Cyclophosphamide, Methotrexate, and Fluorouracil in Node-Positive Breast Cancer
  Martine J. Piccart, Angelo Di Leo, Marc Beauduin, Anita Vindevoghel, Jacques Michel, Christian Focan, Alain Tagnon, Fernand Ries, Philippe Gobert, Claude Finet, Marie T. Closon-Dejardin, Jean P. Dufrane, Joseph Kerger, Françoise Liebens, Sylvie Beauvois, Sylvie Bartholomeus, Stella Dolci, Jean P. Lobelle, Marianne Paesmans, and Jean M. Nogaret
  JCO Jun 15 2001: 3103–3110. [Abstract] [Full Text] [PDF]  
Indicators of Lifetime Estrogen Exposure: Effect on Breast Cancer Incidence and Interaction With Raloxifene Therapy in the Multiple Outcomes of Raloxifene Evaluation Study Participants
  Marc E. Lippman, Kathryn A. Krueger, Stephen Eckert, Andreas Sashegyi, Erin L. Walls, Sophie Jamal, Jane A. Cauley, and Steven R. Cummings
  JCO Jun 15 2001: 3111–3116. [Abstract] [Full Text] [PDF]  
Phase I Trial of Pegylated Liposomal Doxorubicin and Docetaxel in Advanced Breast Cancer
  Joseph A. Sparano, Umekalsoom Malik, Lakshmi Rajdev, Catherine Sarta, Una Hopkins, and Antonio C. Wolff
  JCO Jun 15 2001: 3117–3125. [Abstract] [Full Text] [PDF]  

Phase I and Clinical Pharmacology Back

Carboplatin Skin Testing: A Skin-Testing Protocol for Predicting Hypersensitivity to Carboplatin Chemotherapy
  K. M. Zanotti, L. A. Rybicki, A. W. Kennedy, J. L. Belinson, K. D. Webster, B. Kulp, G. Peterson, and M. Markman
  JCO Jun 15 2001: 3126–3129. [Abstract] [Full Text] [PDF]  
Phase I and Pharmacokinetic Study of the Novel MDR1 and MRP1 Inhibitor Biricodar Administered Alone and in Combination With Doxorubicin
  Ronald A. Peck, Jan Hewett, Matthew W. Harding, Yow-Ming Wang, Pravin R. Chaturvedi, Anish Bhatnagar, Harvey Ziessman, Frank Atkins, and Michael J. Hawkins
  JCO Jun 15 2001: 3130–3141. [Abstract] [Full Text] [PDF]  
 
SPECIAL ARTICLES Back
The Case for a New National Program for the Development of Cancer Therapeutics
Philip S. Schein
JCO Jun 15 2001: 3142–3153. [Full Text] [PDF]  
 
SPECIAL DEPARTMENTS Back

CORRESPONDENCE Back

Clinical Trial Designs for Cytostatic Agents
Mark J. Ratain, Walter M. Stadler, Edward L. Korn, Susan G. Arbuck, James M. Pluda, Richard Simon, Richard S. Kaplan, and Michaele C. Christian
JCO Jun 15 2001: 3154–3155. [Full Text] [PDF]  
Does Detection of Circulating ONYX-015 Genome by Polymerase Chain Reaction Indicate Vector Replication?
Antoine Yver, John J. Nemunaitis, and Casey Cunningham
JCO Jun 15 2001: 3155–3157. [Full Text] [PDF]  
Assessing Adjuvant Breast Cancer Therapy Benefit
Arthur M. Sleeper, Steven M. Sorscher, Leah L. Dietrich, Charles L. Loprinzi, and Stephan D. Thomé
JCO Jun 15 2001: 3157–3159. [Full Text] [PDF]  
Measurement of Brain Tumor Volumes by the Perimeter Method
Charles M. Bagley, Jr and A. Gregory Sorensen
JCO Jun 15 2001: 3159–3160. [Full Text] [PDF]  
Prostate-Specific Antigen Levels in Nipple Aspirate Fluid
Edward R. Sauter and Eleftherios P. Diamandis
JCO Jun 15 2001: 3160. [Full Text] [PDF]  


To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.


About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2008 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online